Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson U.S. consumer first quarter sales flat at $832 mil..

This article was originally published in The Tan Sheet

Executive Summary

JOHNSON & JOHNSON U.S. CONSUMER SALES FLAT AT $832 MIL. in the first quarter, while international consumer sales rose 7.3% to $852 mil. World-wide consumer sales increased 4% to $1.68 bil. for the period. The company said sales continue to be led by the strength of its hair and skin care franchises, which include the Neutrogena, RoC and Clean & Clear product lines

<pre> Chattem Change to 1997 3 Mos. to Feb. 28 1997 1996 from 1996 Sales $ 27.9 mil. $ 18.7 mil. 49.5 % Net income $ 0.14 mil. $ -0.04 mil. --- % Income/share $ 0.02 $ -0.01 Net income/ sales dollar 0.49 cents --- cents PDK Labs Change to 1997 3 Mos. to Feb. 28 1997 1996 from 1996 Sales $ 9.8 mil. $ 9.5 mil. 3.1 % Net income $ 0.34 mil. $ 0.44 mil. -23.0 % Income/share $ 0.08 $ 0.11 Net income/ sales dollar 3.49 cents 4.68 cents Allergan Change to 1997 3 Mos. to March 28 1997 1996 from 1996 Sales $ 256.2 mil. $ 258.1 mil. -0.7 % Net income $ 17.80 mil. $ 23.10 mil. -22.9 % Income/share $ 0.27 $ 0.35 Net income/ sales dollar 6.95 cents 8.95 cents Johnson &amp; Johnson Change to 1997 3 Mos. to March 30 1997 1996 from 1996 Sales $ 5715.0 mil. $ 5334.0 mil. 7.1 % Net income $ 909.00 mil. $ 790.00 mil. 15.1 % Income/share $ 0.68 $ 0.59 Net income/ sales dollar 15.91 cents 14.81 cents Pfizer Change to 1997 3 Mos. to March 30 1997 1996 from 1996 Sales $ 3002.0 mil. $ 2682.0 mil. 11.9 % Net income $ 602.00 mil. $ 517.20 mil. 16.4 % Income/share $ 0.93 $ 0.81 Net income/ sales dollar 20.05 cents 19.28 cents Amrion Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 18.4 mil. $ 13.4 mil. 37.2 % Net income $ 1.63 mil. $ 0.92 mil. 77.0 % Income/share $ 0.30 $ 0.18 Net income/ sales dollar 8.90 cents 6.90 cents CNS Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 19.4 mil. $ 20.8 mil. -6.8 % Net income $ 1.32 mil. $ 3.10 mil. -57.4 % Income/share $ 0.07 $ 0.17 Net income/ sales dollar 6.81 cents 14.89 cents Colgate-Palmolive Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 2147.1 mil. $ 2053.7 mil. 4.5 % Net income $ 169.60 mil. $ 143.50 mil. 18.2 % Income/share $ 1.12 $ 0.95 Net income/ sales dollar 7.90 cents 6.99 cents Nature's Sunshine Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 67.8 mil. $ 60.1 mil. 12.8 % Net income $ 4.01 mil. $ 3.28 mil. 22.4 % Income/share $ 0.21 $ 0.17 Net income/ sales dollar 5.91 cents 5.45 cents Del Labs Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 61.3 mil. $ 56.1 mil. 9.3 % Net income $ 3.30 mil. $ 2.39 mil. 38.0 % Income/share $ 0.52 $ 0.37 Net income/ sales dollar 5.37 cents 4.26 cents Schering-Plough Change to 1997 3 Mos. to March 31 1997 1996 from 1996 Sales $ 1,568.1 mil. $ 1,382.7 mil. 13.0 % Net income $ 375.30 mil. $ 326.30 mil. 15.0 % Income/share $ 1.03 $ 0.89 Net income/ sales dollar 23.93 cents 23.62 cents </pre> <br /> <br />

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel